Published in Arthritis Rheum on May 01, 2005
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum (2011) 3.81
Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science (2013) 2.46
Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis (2005) 2.14
Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California. Cancer Causes Control (2008) 1.93
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies. Arthritis Rheum (2010) 1.54
Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer Res (2012) 1.53
Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun (2013) 1.47
Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome. Ann Rheum Dis (2006) 1.45
Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor. Cell (2015) 1.31
Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis. Br J Cancer (2011) 1.11
Systemic lupus erythematosus in children and adolescents. Pediatr Clin North Am (2012) 1.11
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma. Arthritis Res Ther (2014) 1.04
Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review. Clin Rheumatol (2010) 1.03
Malignancies in systemic lupus erythematosus. Autoimmun Rev (2009) 1.02
Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case-control study. Br J Cancer (2009) 1.01
Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update. J Cancer Epidemiol (2012) 0.95
Incidence of cancer among female patients with systemic lupus erythematosus in Korea. Clin Rheumatol (2009) 0.95
A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study. Ann Rheum Dis (2007) 0.95
AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4. Autoimmunity (2011) 0.94
Primary osteosarcoma of the urinary bladder following cyclophosphamide therapy for systemic lupus erythematosus: a case report. J Med Case Rep (2009) 0.94
Antimalarials may influence the risk of malignancy in systemic lupus erythematosus. Ann Rheum Dis (2007) 0.94
Lung cancer and interstitial lung diseases: a systematic review. Pulm Med (2012) 0.92
Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL). Clin Rheumatol (2007) 0.91
MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis. J Immunol (2011) 0.87
Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy. Int J Clin Exp Pathol (2008) 0.87
Malignancy in systemic lupus erythematosus: what have we learned? Best Pract Res Clin Rheumatol (2009) 0.87
Prostate cancer in systemic lupus erythematosus. Int J Cancer (2011) 0.86
Malignancies associated with systemic lupus erythematosus in Taiwan: a nationwide population-based cohort study. Rheumatol Int (2010) 0.85
Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up. Clin Rheumatol (2009) 0.85
Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus. PLoS One (2010) 0.85
An unusual case of glomerulonephritis in a patient with non-Hodgkin mucosal associated lymphoid tissue (MALT) B-cell lymphoma. BMC Nephrol (2013) 0.85
The identification of specific methylation patterns across different cancers. PLoS One (2015) 0.84
Prevalence of human papilloma virus infections and cervical cytological abnormalities among Korean women with systemic lupus erythematosus. J Korean Med Sci (2010) 0.84
Characteristics of comorbidities and costs among patients who died from systemic lupus erythematosus in Taiwan. Arch Med Sci (2012) 0.84
Immune surveillance and lymphoid malignancy in immunocompromised host. Am J Blood Res (2013) 0.82
Association of rheumatoid arthritis risk with EGFR genetic polymorphisms in Taiwan's Han Chinese population. Rheumatol Int (2011) 0.81
Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy. Lupus Sci Med (2014) 0.81
Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study. Lupus (2013) 0.81
Multimorbidity in rheumatic conditions. Wien Klin Wochenschr (2016) 0.81
B cell tolerance and positive selection in lupus. J Immunol (2012) 0.80
Thirty-day hospital readmissions in systemic lupus erythematosus: predictors and hospital- and state-level variation. Arthritis Rheumatol (2014) 0.80
[Rationale for bone marrow examination in patients with inflammatory rheumatic diseases]. Wien Klin Wochenschr (2009) 0.79
Cancer biology in diabetes. J Diabetes Investig (2014) 0.79
Successful rituximab-CHOP treatment of systemic lupus erythematosus associated with diffuse large B-cell non-Hodgkin lymphoma. Rheumatol Int (2007) 0.79
Cutaneous vasculitis as an initiating paraneoplastic symptom in Hodgkin lymphoma. Rheumatol Int (2007) 0.79
Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus. Clin Immunol (2015) 0.78
Parallel Aspects of the Microenvironment in Cancer and Autoimmune Disease. Mediators Inflamm (2016) 0.78
Genetic polymorphisms of the DNA repair gene UNG are associated with the susceptibility of rheumatoid arthritis. Rheumatol Int (2011) 0.77
Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk? Biomed Res Int (2016) 0.77
Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice. Arthritis Rheumatol (2016) 0.76
MAGE-B2 autoantibody: a new biomarker for pediatric systemic lupus erythematosus. J Rheumatol (2008) 0.76
Autoimmune lymphoproliferative syndrome-like syndrome presented as lupus-like syndrome with mycobacterial joint infection evolved into the lymphoma. Rheumatol Int (2008) 0.76
RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5. PLoS One (2017) 0.75
Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance. BBA Clin (2016) 0.75
Reversing the Paradigm: Protein Kinase C as a Tumor Suppressor. Trends Pharmacol Sci (2017) 0.75
New classification criteria for systemic lupus erythematosus correlate with disease activity. Croat Med J (2014) 0.75
Screening for Anal Cancer in Women. J Low Genit Tract Dis (2015) 0.75
Genomic expression profiling and bioinformatics analysis of pancreatic cancer. Mol Med Rep (2015) 0.75
Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population. Breast Cancer Res Treat (2015) 0.75
Ecology. Ecosystem-based fishery management. Science (2004) 10.15
The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med (1992) 8.53
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum (1991) 7.94
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88
Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res (2004) 6.49
Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation (2004) 6.43
Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA (1997) 6.12
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum (2001) 5.36
The consultant episode: an unhelpful measure. BMJ (1992) 5.35
A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med (1994) 5.04
Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery. Arthritis Rheum (1999) 4.46
NuA4, an essential transcription adaptor/histone H4 acetyltransferase complex containing Esa1p and the ATM-related cofactor Tra1p. EMBO J (1999) 4.14
Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol (1993) 4.13
The genetic testing of children. Working Party of the Clinical Genetics Society (UK) J Med Genet (1994) 4.12
The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum (1990) 3.97
X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet (1996) 3.90
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
Placing trials in context using Bayesian analysis. GUSTO revisited by Reverend Bayes. JAMA (1995) 3.73
Quality control of mRNA 3'-end processing is linked to the nuclear exosome. Nature (2001) 3.69
Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat Cell Biol (2001) 3.62
Mortality in systemic lupus erythematosus. Arthritis Rheum (2006) 3.61
Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells. Nature (1990) 3.57
Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA (1997) 3.47
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. Arthritis Rheum (1996) 3.40
Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. BMJ (1995) 3.40
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med (1993) 3.35
Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A (1998) 3.35
Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med (1994) 3.32
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
Efficient purchasing. BMJ (1993) 3.31
Bayesian interim statistical analysis of randomised trials. Lancet (1997) 3.06
Yeast SAS silencing genes and human genes associated with AML and HIV-1 Tat interactions are homologous with acetyltransferases. Nat Genet (1996) 3.02
A comparison of the reliability of self-reported drug use and sexual behaviors using computer-assisted versus face-to-face interviewing. AIDS Educ Prev (2000) 3.02
Measuring readmission rates. BMJ (1990) 3.01
Should we test children for "adult" genetic diseases? Lancet (1990) 2.97
The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum (1995) 2.82
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus (2000) 2.81
Birth of a biome: insights into the assembly and maintenance of the Australian arid zone biota. Mol Ecol (2008) 2.73
Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests. Biometrics (2001) 2.72
Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry. JAMA (2001) 2.70
Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis (2001) 2.69
Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum (2001) 2.68
Guidelines, enthusiasms, uncertainty, and the limits to purchasing. BMJ (1995) 2.59
Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol (1997) 2.59
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 2.49
A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J (1998) 2.43
A block to mRNA nuclear export in S. cerevisiae leads to hyperadenylation of transcripts that accumulate at the site of transcription. Mol Cell (2001) 2.41
Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2000) 2.40
The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int (2007) 2.40
Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest (1996) 2.39
Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum (1995) 2.38
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) (2005) 2.37